Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1520
-
Total 13F shares, excl. options
-
1,022,396,822
-
Shares change
-
+28,237,867
-
Total reported value, excl. options
-
$78,869,235,633
-
Value change
-
+$2,219,917,371
-
Put/Call ratio
-
1.46%
-
Number of buys
-
612
-
Number of sells
-
-766
-
Price
-
$77.21
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2018
1,668 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2018.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,520 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,022,396,822 shares
of 1,240,722,841 outstanding shares and own 82.4% of the company stock.
Largest 10 shareholders include BlackRock Inc. (101,990,129 shares), Vanguard Group Inc (97,167,329 shares), Capital Research Global Investors (69,854,968 shares), STATE STREET CORP (56,015,307 shares), Bank of New York Mellon Corp (31,350,714 shares), FMR LLC (18,210,622 shares), Invesco Ltd. (17,505,660 shares), NORTHERN TRUST CORP (16,606,713 shares), DODGE & COX (16,450,181 shares), and JPMORGAN CHASE & CO (16,159,381 shares).
This table shows the top 1520 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.